Cargando…
Potential inhibition of HIV-1 encapsidation by oligoribonucleotide–dendrimer nanoparticle complexes
BACKGROUND: Encapsidation, the process during which the genomic RNA of HIV is packaged into viral particles, is an attractive target for antiviral therapy. This study explores a novel nanotechnology-based strategy to inhibit HIV encapsidation by an RNA decoy mechanism. The design of the 16-mer oligo...
Autores principales: | Parboosing, Raveen, Chonco, Louis, de la Mata, Francisco Javier, Govender, Thavendran, Maguire, Glenn EM, Kruger, Hendrik G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221794/ https://www.ncbi.nlm.nih.gov/pubmed/28115849 http://dx.doi.org/10.2147/IJN.S114446 |
Ejemplares similares
-
Nanotechnology and the Treatment of HIV Infection
por: Parboosing, Raveen, et al.
Publicado: (2012) -
Molecular modelling studies of synthesized pentacyclo-undecane peptides as potential HIV-1 wild type C-SA protease inhibitors
por: Honarparvar, Bahareh, et al.
Publicado: (2013) -
{(1R,3S)-2-Benzyl-6,7-dimethoxy-1-phenyl-1,2,3,4-tetrahydroisoquinolin-3-yl}diphenylmethanol
por: Naicker, Tricia, et al.
Publicado: (2010) -
(S)-N-Benzyl-2-methyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide
por: Naicker, Tricia, et al.
Publicado: (2010) -
Pentacycloundecane lactam vs lactone norstatine type protease HIV inhibitors: binding energy calculations and DFT study
por: Honarparvar, Bahareh, et al.
Publicado: (2015)